HCWB
HCW Biologics Inc.
+0.05 (+2.49%)2.06USD43.3K成交股數3.8M市值0.1本益比(近四季)0.6股價營收比+1758.5%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 122K+2303% | 6.5M+1546% | 16K-96% | 7K-99% | 5K-100% | 395K-54% | 426K-32% | 619K+1378% | 1.1M | 853K | 623K | 42K |
| 營業成本 | 229K | 11K | 12K | 5K | 4K | 316K | 341K | 438K | 512K | 678K | 502K | 29K |
| 毛利 | −94K-9368% | 6.5M+8172% | 3K-96% | 1K-99% | 1K-100% | 79K-55% | 85K-29% | 180K+1339% | 615K | 175K | 120K | 13K |
| 毛利率 | -77.1% | 100.5% | 20.0% | 20.0% | 20.0% | 20.0% | 20.0% | 29.2% | 54.6% | 20.5% | 19.3% | 29.9% |
| 研發費用 | 1.2M | 1.3M | 1.4M | 1.2M | 1.5M | 1.0M | 1.2M | 2.0M | 2.1M | 1.7M | 1.6M | 2.3M |
| 銷售管理費用 | 1.9M | 1.8M | 1.9M | 2.1M | 2.2M | 2.0M | 1.6M | 1.6M | 1.6M | 1.5M | 1.6M | 3.1M |
| 營業利益 | −3.2M+61% | 3.2M-203% | −3.3M-11% | −3.5M-77% | −2.0M-74% | −3.1M-38% | −3.7M-18% | −15.1M+182% | −7.5M | −5.1M | −4.5M | −5.4M |
| 營業利益率 | -2,601.1% | 49.8% | -21,095.3% | -52,886.7% | -38,811.5% | -795.9% | -864.1% | -2,445.8% | -665.1% | -595.2% | -724.2% | -12,798.9% |
| 稅後淨利 | −5.2M+138% | 3.5M-203% | −4.6M+17% | −1.9M-87% | −2.2M-71% | −3.4M-32% | −3.9M-9% | −15.3M+201% | −7.5M | −4.9M | −4.3M | −5.1M |
| 淨利率 | -4,287.5% | 53.4% | -29,183.2% | -29,431.0% | -43,373.6% | -854.4% | -915.1% | -2,469.1% | -662.8% | -578.9% | -691.1% | -12,106.8% |
| 稀釋 EPS | -11.58-2% | 1.39-113% | -2.02-51% | -40.72+152% | -11.80+5800% | -10.47+7379% | -4.13+3342% | -16.16+11443% | -0.20 | -0.14 | -0.12 | -0.14 |
| 稀釋股數 | 1.3M | 904K | 2.3M | 297K | 186K | 970K | 946K | 946K | 37.2M | 35.9M | 35.9M | 35.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 741K | 1.2M | 1.1M | 2.4M | 1.1M | 4.7M | 998K | 1.2M | 4.1M | 11.2M | 7.4M | 18.4M |
| 應收帳款 | 18K | 75K | 31K | 22K | 87K | 582K | 652K | 655K | 904K | 710K | 707K | 253K |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 26.8M | 27.3M | 25.4M | 28.9M | 26.3M | 30.2M | 26.6M | 26.8M | 30.4M | 35.6M | 39.5M | 43.5M |
| 有息負債 | – | – | 0.00 | 367K | 7.7M | 7.4M | 6.5M | 9.9M | 8.3M | 6.3M | 6.4M | 6.4M |
| 總負債 | 19.3M | 21.6M | 27.6M | 29.0M | 34.8M | 37.0M | 36.5M | 33.1M | 21.7M | 11.7M | 10.9M | 10.9M |
| 股東權益 | 7.4M | 5.8M | −2.1M | −52K | −8.6M | −6.8M | −10.0M | −6.3M | 8.7M | 23.9M | 28.6M | 32.6M |
| 負債比 | 72.3% | 78.9% | 108.3% | 100.2% | 132.6% | 122.4% | 137.5% | 123.5% | 71.3% | 33.0% | 27.6% | 25.1% |
| 淨現金(現金 − 有息負債) | – | – | 1.1M | 2.1M | −6.6M | −2.7M | −5.5M | −8.7M | −4.2M | 4.9M | 1.1M | 12.0M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −1.6M | – | – | −3.5M-2% | – | – | – | −3.6M | – | – | −3.6M |
| 資本支出 | – | – | – | – | 0.00 | – | – | – | 130K | – | – | 300K |
| 自由現金流 | – | – | – | – | −3.5M-6% | – | – | – | −3.7M | – | – | −3.9M |
| 折舊攤銷 | – | 142K | – | – | 419K | – | – | – | 244K | – | – | 299K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | -69,375.2% | – | – | – | -331.4% | – | – | -9,403.8% |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 54K | -97.9% | −8.0M | -14,677.1% | -10.63 | −13.4M |
| FY2024 | 2.6M | -9.7% | −30.0M | -1,169.7% | -30.96 | −14.5M |
| FY2023 | 2.8M | -57.7% | −25.0M | -879.5% | -0.70 | −28.7M |
| FY2022 | 6.7M | – | −14.9M | -221.7% | -0.42 | −20.7M |
| FY2021 | 0.00 | -100.0% | −12.9M | –% | -0.69 | −11.0M |
| FY2020 | 4.1M | – | −5.8M | -141.5% | -1.49 | −10.6M |